Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been newly diagnosed with classical Hodgkin lymphoma, confirmed through a tissue sample (biopsy)
- People who have signed the official consent form agreeing to take part in the trial
Who may not be able to join:
- People who have not signed the official consent form for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Heidi Mocikova, M.D., Ph.D., Faculty Hospital Kralovske Vinohrady
Phone: +420267163554
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of tumor specific mutation profiles at dg. of HL based on ctDNA; Quantitative analysis of ctDNA level during the first-line chemotherapy; Identification of tumor specific mutation profiles at relapse of classical HL
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.